Normal Comparison Subjects |
Subjects With Schizophrenia |
Cortical Area |
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pair | Sex | Race | Age (years) | Postmortem Interval (hours) |
RNA Integritya |
Storage Time (months)b |
Cause of Death |
Sex | Race | Age (years) | Postmortem Interval (hours) |
RNA Integritya |
Storage Time (months)b |
Cause of Death |
DSM-IV Diagnosis |
Area 9 | Area 24 | Area 4 | Area 17 |
1 | Male | Black | 41 | 22.1 | 9.0 | 116 | Atherosclerotic coronary vascular disease | Male | White | 40 | 29.1 | 8.4 | 126 | Accidental asphyxiation | Chronic undifferentiated schizophrenia | √ | √ | √ | √ |
2 | Male | Black | 20 | 14.0 | 8.4 | 127 | Gun shot wound to chest | Male | Black | 27 | 16.5 | 7.4 | 123 | Heat stroke | Schizoaffective disorderc, d | √ | √ | √ | √ |
3 | Male | White | 65 | 21.2 | 9.0 | 110 | Atherosclerotic coronary vascular disease | Male | White | 63 | 18.3 | 8.0 | 120 | Atherosclerotic coronary vascular disease | Chronic undifferentiated schizophreniac, e | √ | √ | √ | √ |
4 | Male | White | 39 | 19.3 | 8.6 | 113 | Hypoplastic coronary artery disease | Male | White | 46 | 28.1 | 7.9 | 118 | Accidental combined drug overdose | Chronic paranoid schizophreniac, d, f, g | √ | √ | √ | √ |
5 | Male | White | 56 | 14.5 | 8.1 | 103 | Hypoplastic coronary artery disease | Male | White | 58 | 18.9 | 7.4 | 111 | Right middle cerebral artery infarction | Chronic undifferentiated schizophreniah | √ | √ | √ | √ |
6 | Male | Black | 19 | 7.0 | 9.2 | 96 | Trauma | Male | White | 25 | 5.0 | 9.3 | 77 | Suicide by drug overdose | Schizoaffective disorderc, d, f, h, i | √ | √ | √ | √ |
7 | Female | Black | 55 | 11.3 | 9.6 | 118 | Atherosclerotic coronary vascular disease | Female | White | 48 | 3.7 | 9.3 | 127 | Intracerebral hemmorrhage | Chronic disorganized schizophreniaf | √ | √ | ||
8 | Male | White | 42 | 26.1 | 8.7 | 100 | Atherosclerotic coronary vascular disease | Male | White | 50 | 40.5 | 8.1 | 125 | Suicide by combined drug overdose | Schizoaffective disorderd, j | √ | √ | √ | √ |
9 | Male | White | 54 | 8.0 | 9.1 | 72 | Cardiac tamponade | Male | Black | 52 | 8.0 | 7.7 | 87 | Peritonitis | Schizoaffective disorderj | √ | √ | ||
10 | Female | White | 73 | 19.7 | 7.7 | 10 | Anaphylactic reaction | Female | White | 71 | 23.8 | 7.0 | 60 | Atherosclerotic coronary vascular disease | Chronic undifferentiated schizophrenia | √ | √ | √ | |
11 | Male | White | 48 | 16.6 | 8.9 | 71 | Atherosclerotic coronary vascular disease | Male | White | 47 | 15.7 | 8.2 | 57 | Atherosclerotic coronary vascular disease | Continuous disorganized schizophreniad, i, j | √ | √ | √ | √ |
12 | Male | White | 40 | 15.8 | 8.4 | 95 | Atherosclerotic coronary vascular disease | Male | White | 44 | 8.3 | 8.1 | 56 | Myocarditis | Disorganized schizophreniad | √ | √ | √ |
Assessed as RNA integrity number and measured on the Agilent 2100 bioanalyzer (Agilent Technologies, Santa Clara, Calif.).
Tissue stored at −80°C.
Taking benzodiazepines at time of death.
Taking valproic acid at time of death.
Alcohol abuse in remission at time of death.
Alcohol dependence current at time of death.
Other substance abuse current at time of death.
Not taking antipsychotic medication at time of death.
Other substance abuse in remission at time of death.
Alcohol dependence in remission at time of death.